- Investor's Business Daily•6 days ago
Sales of Pacira's painkiller Exparel toppled 2% in February and will have to reaccelerate in March to meet an analyst's 2017 views.
- GlobeNewswire•13 days ago
PARSIPPANY, N. J. and LIVONIA, Mich., March 16, 2017-- Trinity Health, one of the largest hospital systems in the nation, and Pacira Pharmaceuticals, Inc., today announced they will collaborate to develop ...
- Motley Fool•14 days ago
Growing use of this company's opioid alternative is fueling investor optimism.
PCRX : Summary for Pacira Pharmaceuticals, Inc. - Yahoo Finance
Pacira Pharmaceuticals, Inc. (PCRX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||45.40 x 100|
|Ask||73.00 x 100|
|Day's Range||46.25 - 48.10|
|52 Week Range||29.95 - 65.64|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-46.47|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|